A jab given to patients to battle RSV through the NHS could potentially cause a disabling condition known as Guillain-Barré Syndrome, according to experts in the US ...

Valneva SE (“Valneva”) announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...

US regulators have approved a new meningitis vaccine developed by GSK, sparking cautious optimism for the sector in the wake ...

Freshly confirmed by the U.S. Senate, Health Secretary Robert F. Kennedy Jr. told a room packed with federal health workers ...